prikaz prve stranice dokumenta Renal replacement therapy in Europe: a summary of the 2013 ERA- EDTA Registry Annual Report with a focus on diabetes mellitus
  Download
PDF 1.13 MB
Scientific paper - Original scientific paper
Renal replacement therapy in Europe: a summary of the 2013 ERA- EDTA Registry Annual Report with a focus on diabetes mellitus
Clinical Kidney Journal, 9 (2016), 3; 457-469. https://doi.org/10.1093/ckj/sfv151
Kramer, Anneke; Pippias, Maria; Stel, Vianda S.; Bonthuis, Marjolein; Abad Diez, José Maria; Afentakis, Nikolaos; Alonso de la Torre, Ramón; Ambühl, Patrice M.; Bikbov, Boris; Bouzas Caamaño, Encarnación; Bubić, Ivan; Buturović-Ponikvar, Jadranka; Caskey, Fergus J.; Castro de la Nuez, Pablo; Cernevskis, Harijs; Collart, Frederic; Comas Farnés, Jordi; Garcia Bazaga, Maria de los Ángeles; De Meester, Johan; Ferrer-Alamar, Manuel; Finne, Patrik; Garneata, Liliana; Golan, Eliezer; G. Heaf, James; Hemmelder, Marc H.; Ioannou, Kyriakos; Kantaria, Nino; Kolesnyk, Mykola; Kramar, Reinhard; Lassalle, Mathilde; Lezaić, Višnja; Lopot, Frantisek; Macário, Fernando; Magaz, Angela; Martín-Escobar, Eduardo; Metcalfe, Wendy; Ots-Rosenberg, Mai; Palsson, Runolfur; Piñera Celestino, Celestino; Resić, Halima; Rutkowski, Boleslaw; Santiuste de Pablos, Carmen; Spustová, Viera; Stendahl, Maria; Strakosha, Ariana; Süleymanlar, Gültekin; Torres Guinea, Marta; Varberg Reisæter, Anna; Vazelov, Evgueniy; Ziginskiene, Edita; Massy, Ziad A.; Wanner, Christoph; Jager, Kitty J.; Noordzij, Marlies More authors...

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

Kramer, A., Pippias, M., Stel, V. S., Bonthuis, M., Abad Diez, J. M., Afentakis, N. ... Noordzij, M. (2016). Renal replacement therapy in Europe: a summary of the 2013 ERA- EDTA Registry Annual Report with a focus on diabetes mellitus. Clinical Kidney Journal, 9. (3), 457-469. doi: 10.1093/ckj/sfv151

Kramer, Anneke, et al. "Renal replacement therapy in Europe: a summary of the 2013 ERA- EDTA Registry Annual Report with a focus on diabetes mellitus." Clinical Kidney Journal, vol. 9, no. 3, 2016, pp. 457-469. https://doi.org/10.1093/ckj/sfv151

Kramer, Anneke, Maria Pippias, Vianda S. Stel, Marjolein Bonthuis, José Maria Abad Diez, Nikolaos Afentakis, Ramón Alonso de la Torre, et al. "Renal replacement therapy in Europe: a summary of the 2013 ERA- EDTA Registry Annual Report with a focus on diabetes mellitus." Clinical Kidney Journal 9, no. 3 (2016): 457-469. https://doi.org/10.1093/ckj/sfv151

Kramer, A., et al. (2016) 'Renal replacement therapy in Europe: a summary of the 2013 ERA- EDTA Registry Annual Report with a focus on diabetes mellitus', Clinical Kidney Journal, 9(3), pp. 457-469. doi: 10.1093/ckj/sfv151

Kramer A, Pippias M, Stel VS, Bonthuis M, Abad Diez JM, Afentakis N, and sur.. Renal replacement therapy in Europe: a summary of the 2013 ERA- EDTA Registry Annual Report with a focus on diabetes mellitus. Clinical Kidney Journal [Internet]. 2016 [cited 2024 May 14];9(3):457-469. doi: 10.1093/ckj/sfv151

A. Kramer, et al., "Renal replacement therapy in Europe: a summary of the 2013 ERA- EDTA Registry Annual Report with a focus on diabetes mellitus", Clinical Kidney Journal, vol. 9, no. 3, pp. 457-469, 2016. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:422448. [Accessed: 14 May 2024]

Metadata
Title (english)Renal replacement therapy in Europe: a summary of the 2013 ERA- EDTA Registry Annual Report with a focus on diabetes mellitus
AuthorAnneke Kramer
AuthorMaria Pippias
AuthorVianda S. Stel
AuthorMarjolein Bonthuis
AuthorJosé Maria Abad Diez
AuthorNikolaos Afentakis
AuthorRamón Alonso de la Torre
AuthorPatrice M. Ambühl
AuthorBoris Bikbov
AuthorEncarnación Bouzas Caamaño
AuthorIvan Bubić
AuthorJadranka Buturović-Ponikvar
AuthorFergus J. Caskey
AuthorPablo Castro de la Nuez
AuthorHarijs Cernevskis
AuthorFrederic Collart
AuthorJordi Comas Farnés
AuthorMaria de los Ángeles Garcia Bazaga
AuthorJohan De Meester
AuthorManuel Ferrer-Alamar
AuthorPatrik Finne
AuthorLiliana Garneata
AuthorEliezer Golan
AuthorJames G. Heaf
AuthorMarc H. Hemmelder
AuthorKyriakos Ioannou
AuthorNino Kantaria
AuthorMykola Kolesnyk
AuthorReinhard Kramar
AuthorMathilde Lassalle
AuthorVišnja Lezaić
AuthorFrantisek Lopot
AuthorFernando Macário
AuthorAngela Magaz
AuthorEduardo Martín-Escobar
AuthorWendy Metcalfe
AuthorMai Ots-Rosenberg
AuthorRunolfur Palsson
AuthorCelestino Piñera Celestino
AuthorHalima Resić
AuthorBoleslaw Rutkowski
AuthorCarmen Santiuste de Pablos
AuthorViera Spustová
AuthorMaria Stendahl
AuthorAriana Strakosha
AuthorGültekin Süleymanlar
AuthorMarta Torres Guinea
AuthorAnna Varberg Reisæter
AuthorEvgueniy Vazelov
AuthorEdita Ziginskiene
AuthorZiad A. Massy
AuthorChristoph Wanner
AuthorKitty J. Jager
AuthorMarlies Noordzij
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (english)
Background: This article provides a summary of the 2013 European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report (available at http://www.era- edta-reg.org), with a focus on patients with diabetes mellitus (DM) as the cause of end-stage renal disease (ESRD). Methods: In 2015, the ERA-EDTA Registry received data on renal replacement therapy (RRT) for ESRD from 49 national or regional renal registries in 34 countries in Europe and bordering the Mediterranean Sea. Individual patient data were provided by 31 registries, while 18 registries provided aggregated data. The total population covered by the participating registries comprised 650 million people. Results: In total, 72 933 patients started RRT for ESRD within the countries and regions reporting to the ERA-EDTA Registry, resulting in an overall incidence of 112 per million population (pmp). The overall prevalence on 31 December 2013 was 738 pmp (n = 478 990). Patients with DM as the cause of ESRD comprised 24% of the incident RRT patients (26 pmp) and 17% of the prevalent RRT patients (122 pmp). When compared with the USA, the incidence of patients starting RRT pmp secondary to DM in Europe was five times lower and the incidence of RRT due to other causes of ESRD was two times lower. Overall, 19 426 kidney transplants were performed (30 pmp). The 5-year adjusted survival for all RRT patients was 60.9% [95% confidence interval (CI) 60.5-61.3] and 50.6% (95% CI 49.9- 51.2) for patients with DM as the cause of ESRD.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleClinical Kidney Journal
Numberingvol. 9, no. 3, pp. 457-469
p-ISSN2048-8505
DOIhttps://doi.org/10.1093/ckj/sfv151
URN:NBNurn:nbn:hr:184:422448
Publication2016
Document URLhttp://bib.irb.hr/1106474
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) icon
Created on2022-03-08 12:22:38